menu search

fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- fulcrum Therapeutics, Inc.® (the “Company”) (N...

October 31, 2023, 8:50 am

An updated view on fulcrum therapeutics

fulcrum Therapeutics, Inc. has had some key potential catalysts resolved positively recently. These inc...

September 25, 2023, 2:10 pm

fulcrum (fulc) up as fda lifts clinical hold on scd candidate

Fulcrum's (FULC) shares surge as the FDA lifts the clinical hold it had earlier placed on its pipeline candidate FTX-6058, to treat patients with sick...

August 24, 2023, 9:46 am

Options traders blast biotech stock on fda buzz

fulcrum Therapeutics Inc (NASDAQ:FULC) is up 49.7% to trade at $5.87 at last glance -- its highest leve...

August 22, 2023, 2:59 pm

Midday movers: febrinet, sidus space, fulcrum, republic first, dick's, baidu, and more

Fabrinet sees record high Fabrinet (NYSE:FN) stock is at a record high, rising over 27% to around US$149, after the manufacturer revealed impressive f...

August 22, 2023, 1:21 pm

Why is fulcrum therapeutics (fulc) stock up 43% today?

fulcrum Therapeutics (NASDAQ: FULC ) stock is on the rise Tuesday as investors react to positive news f...

August 22, 2023, 9:39 am

fulcrum therapeutics shares skyrocket as fda lifts clinical hold on sickle cell disease trial

fulcrum Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical...

August 22, 2023, 8:54 am

fulcrum utility services to cancel listing as shares plummet

fulcrum Utility Services Ltd (AIM:FCRM), the energy infrastructure group, shed more than two-thirds of ...

August 21, 2023, 4:48 am

fulcrum therapeutics, inc. (fulc) q2 2023 earnings call transcript

fulcrum Therapeutics, Inc. (NASDAQ:FULC ) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Co...

August 5, 2023, 5:18 am

fulcrum therapeutics announces recent business highlights and financial results for second quarter 2023

― Screening closed for the Phase 3 REACH pivotal trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) ― ― Expect to report topli...

August 3, 2023, 11:01 am

fulcrum therapeutics, inc. (fulc) reports q2 loss, lags revenue estimates

fulcrum Therapeutics, Inc. (FULC) came out with a quarterly loss of $0.38 per share versus the Zacks Co...

August 3, 2023, 9:48 am

Fulc final deadline alert: rosen, global investor counsel, encourages fulcrum therapeutics, inc. investors to secure counsel before important june 27 deadline in securities class action – fulc

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

June 24, 2023, 5:18 pm

Fulc shareholder alert: jakubowitz law reminds fulcrum shareholders of a lead plaintiff deadline of june 27, 2023

NEW YORK, June 14, 2023 (GLOBE NEWSWIRE) — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of sharehol...

June 14, 2023, 4:26 pm

Rosen, top ranked global investor counsel, encourages fulcrum therapeutics, inc. investors to secure counsel before important june 27 deadline in securities class action – fulc

NEW YORK, June 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

June 14, 2023, 1:02 am

fulcrum therapeutics, inc. (fulc) class action: robbins llp reminds investors of lead plaintiff deadline in fulcrum therapeutics, inc. class action case

SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entit...

June 12, 2023, 11:22 pm

Rosen, a top ranked law firm, encourages fulcrum therapeutics, inc. investors with losses exceeding $100k to secure counsel before important deadline in securities class action – fulc

WHY: NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

June 10, 2023, 2:30 am

Rosen, a leading national firm, encourages fulcrum therapeutics, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – fulc

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

June 5, 2023, 6:23 pm

Rosen, national trial lawyers, encourages fulcrum therapeutics, inc. investors with losses to secure counsel before important deadline in securities class action – fulc

NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

May 28, 2023, 2:11 am

fulcrum therapeutics: fshd steadily advancing in phase 3, optionality with scd

Crisis of confidence in prior management (related to full clinical hold in February for FTX-6058 in SCD) led to currently cheap valuation. New CEO (ap...

May 24, 2023, 2:15 pm

fulcrum therapeutics, inc. (fulc) equity alert: contact robbins llp to learn about the fulcrum therapeutics, inc. securities fraud class action and lead plaintiff deadline

SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entiti...

May 23, 2023, 10:26 pm


Search within

Pages Search Results: